[HTML][HTML] Ras-mediated deregulation of the circadian clock in cancer

…, S Reischl, S Bervoets, E Gloc, P Riemer… - PLoS …, 2014 - journals.plos.org
Circadian rhythms are essential to the temporal regulation of molecular processes in living
systems and as such to life itself. Deregulation of these rhythms leads to failures in biological …

Road to precision: recombinase-based targeting technologies for genome engineering

D Wirth, L Gama-Norton, P Riemer, U Sandhu… - Current opinion in …, 2007 - Elsevier
In the past years, recombinase-based approaches for integrating transgenes into defined
chromosomal loci of mammalian cells have gained increasing attention. This method is …

[HTML][HTML] Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance

M Morkel, P Riemer, H Bläker, C Sers - Oncotarget, 2015 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is characterized by recurrent mutations deregulating key cell
signaling cascades and providing the cancer cells with novel functional traits. Among the most …

[HTML][HTML] Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium

…, T Sell, M Lüthen, F Uhlitz, B Klinger, P Riemer… - Nature …, 2019 - nature.com
Oncogenic mutations in KRAS or BRAF are frequent in colorectal cancer and activate the
ERK kinase. Here, we find graded ERK phosphorylation correlating with cell differentiation in …

[HTML][HTML] DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors

T Simon, P Riemer, A Jarosch, K Detjen… - Genome medicine, 2022 - Springer
Background Pancreatic neuroendocrine neoplasms (PanNENs) fall into two subclasses: the
well-differentiated, low- to high-grade pancreatic neuroendocrine tumors (PanNETs), and …

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer

GB Schulz, T Grimm, C Sers, P Riemer… - … Oncology: Seminars and …, 2019 - Elsevier
Objective Dysregulation of the extracellular matrix molecule biglycan (BGN) predicts poor
survival in several cancer entities. Our study investigated the prognostic impact of BGN in …

[PDF][PDF] SFPQ depletion is synthetically lethal with BRAFV600E in colorectal cancer cells

…, B Klinger, M Rivera, N Bublitz, F Uhlitz, P Riemer… - Cell reports, 2020 - cell.com
Oncoproteins such as the BRAF V600E kinase endow cancer cells with malignant properties,
but they also create unique vulnerabilities. Targeting of BRAF V600E -driven cytoplasmic …

Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity

P Riemer, A Sreekumar, S Reinke, R Rad, R Schäfer… - Oncogene, 2015 - nature.com
Colon cancer cells frequently carry mutations that activate the β-catenin and mitogen-activated
protein kinase (MAPK) signaling cascades. Yet how oncogenic alterations interact to …

Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells

U Sandhu, M Cebula, S Behme, P Riemer… - Nucleic acids …, 2011 - academic.oup.com
Recombinant mouse strains that harbor tightly controlled transgene expression proved to be
indispensible tools to elucidate gene function. Different strategies have been employed to …

Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation

…, L Zha, S Spencer, S Behme, P Riemer… - Nucleic acids …, 2017 - academic.oup.com
Faithful expression of transgenes in cell cultures and mice is often challenged by locus
dependent epigenetic silencing. We investigated silencing of Tet-controlled expression cassettes …